Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. It also exports its products to Europe, the United Kingdom, Australia, Sri Lanka, Africa, Philippines, Tanzania, Nigeria, and Commonwealth countries. Bafna Pharmaceuticals Limited was founded in 1981 and is based in Chennai, India. Bafna Pharmaceuticals Limited is a subsidiary of SRJR Lifesciences LLP.
| Current Price | ₹145.41 |
|---|---|
| Market Cap | ₹344 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Pharmaceutical Products |
| P/E Ratio | 31 |
| Return on Equity | 12.27% |
| 52-Week Range | ₹72.01 – ₹202.06 |
| Beta (1Y) | 0.44 |
Bafna Pharmaceuticals Ltd. is trading at ₹145.41, with a market capitalisation of ₹344 Cr.
Bafna Pharmaceuticals Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Pharmaceutical Products).
Bafna Pharmaceuticals Ltd. has a P/E of 31 and a return on equity of 12.27%.